Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment? (Q45965286)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment? |
scientific article |
Statements
1 reference
Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment? (English)
1 reference
Jung Hyun Kwon
1 reference
Jeong Won Jang
1 reference
Jong Young Choi
1 reference
Chung-Hwa Park
1 reference
Sun Hong Yoo
1 reference
Si Hyun Bae
1 reference
Seung Kew Yoon
1 reference
1 January 2013
1 reference
1 reference
85
1 reference
34-42
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference